Log in or Sign up for Free to view tailored content for your specialty!
Sjögren’s Syndrome News
No link between ethnicity, neonatal lupus erythematosus risk
There is no association between a child’s ethnicity and the risk for neonatal lupus erythematosus, nor for any specific disease symptoms, according to data published in The Journal of Rheumatology.
Maternal ankylosing spondylitis linked to twofold higher Kawasaki disease risk in children
Maternal ankylosing spondylitis is associated with a 2.02-times higher likelihood of Kawasaki disease in the offspring, according to a research letter published in JAMA Network Open.
Log in or Sign up for Free to view tailored content for your specialty!
Biologics and Sjögren's syndrome: Seek payer approval for disease manifestations
The ability to identify the features of Sjögren’s syndrome, and to seek payer approval for specific manifestations of the disease, is of paramount importance for the rheumatologist, according to a presenter at the 2021 Interdisciplinary Autoimmune Summit.
Rituximab should be 'prescribed with caution' due to possible risk for severe COVID-19
Rituximab was associated with more severe COVID-19 in patients with inflammatory rheumatic and musculoskeletal diseases, according to data published in The Lancet Rheumatology.
Scleritis incidence drops 34% in UK over 22 years, 'likely' due to improved IMID care
The incidence of scleritis declined by about a third in the United Kingdom between 1997 and 2018, according to data published in Arthritis & Rheumatology.
Autoimmune disease, rituximab linked to higher risk for severe COVID-19 pneumonia
Patients with inflammatory rheumatic disease, but especially those with autoimmune conditions, as well as those treated with rituximab, may be at greater risk for severe COVID-19 pneumonia than the general population, according to data.
COVID-19 more severe than influenza in patients with autoimmune disease
COVID-19 is more severe, with more complications and higher mortality, than influenza among patients with autoimmune disease, according to data published in Rheumatology.
Checkpoint inhibitor response, adverse event rate similar regardless of autoimmune disease
Patients’ response to anti-CTLA-4 or anti-PD-1 checkpoint therapy for advanced melanoma, and their incidence of immune-related adverse events of grade 3 or higher, were similar regardless of preexisting autoimmune disease, according to data.
Risks for severe COVID-19 outcomes in patients with rheumatic disease 'remain substantial'
Although the risk for severe COVID-19 outcomes in patients with rheumatic and musculoskeletal disease has lowered, it is nonetheless still significant, according to data published in The Lancet Rheumatology.
Patients with systemic autoimmune rheumatic diseases, COVID-19 at greater risk for VTE
Patients with systemic autoimmune rheumatic diseases and COVID-19 may be at greater risk for hospitalization, ICU admission, acute renal failure and venous thromboembolism, according to data published in Arthritis & Rheumatology.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read